Why CCRAS Is Demanding Stricter Drug Safety in Ayurveda
The Central Council for Research in Ayurvedic Sciences has urged researchers to strengthen scientific evidence and clinical safety monitoring. Specifically, developing structured pharmacovigilance in Ayurveda remains vital for broader market adoption and clinical credibility. CCRAS Director General Dr Rabinarayan Acharya addressed this priority at the National Symposium held at CARI Bengaluru. Therefore, healthcare leaders must validate traditional remedies to ensure reliable care for non-communicable diseases.
CCRAS and Pharmacovigilance in Ayurveda
Ayurvedic pharmacovigilance has evolved significantly over the past three decades. Dr Acharya traced this progression from early academic lectures in 1996 to today's nationwide surveillance networks. Furthermore, classical Ayurvedic literature has always recognized the importance of managing adverse events. For instance, the Charaka Samhita documents Basti Vyapad to describe complications arising from improperly administered enema therapies. Thus, classical texts provide an early conceptual foundation for contemporary pharmacovigilance practices. Today, the All India Institute of Ayurveda leads the National Pharmacovigilance Coordination Centre to monitor adverse drug reactions systematically.
Integrative Collaborations and Safety in Clinical Practice
Healthcare systems increasingly integrate Ayurvedic formulations alongside conventional therapeutic regimens. Because of this shift, clinicians must prevent harmful herb-drug interactions through rigorous post-market surveillance. CCRAS Deputy Director General Dr Narayanam Srikanth highlighted ongoing research collaborations with the Indian Council of Medical Research. These joint initiatives target pressing public health domains such as oncology, geriatric care, and reproductive health. In addition, CCRAS actively investigates safety protocols for Panchakarma therapies and validates formulations like Punarnava Mandoora. Consequently, structured adverse drug reaction reporting shields vulnerable patients and eliminates misleading commercial claims.
Frequently Asked Questions
Q1: Why is pharmacovigilance essential for Ayurvedic medicines?
Although many consumers consider natural medicines inherently safe, improper dosing, herb-drug interactions, or poor processing can cause adverse events. Systematic monitoring ensures early detection of safety signals and protects patient health.
Q2: Which central authority coordinates Ayurvedic pharmacovigilance in India?
The National Pharmacovigilance Coordination Centre, located at the All India Institute of Ayurveda in New Delhi, oversees nationwide monitoring in coordination with the Ministry of Ayush.
Q3: What classical concepts support modern drug safety monitoring in Ayurveda?
Classical Ayurvedic treatises, including the Charaka Samhita, thoroughly detailed procedural and drug-induced complications, such as Basti Vyapad, establishing foundational guidelines for therapeutic safety.
To explore more professional medical programs and safe prescribing practices, medical practitioners can enhance their expertise through structured online learning.
References
- Ayurveda needs stronger evidence, safety monitoring for market adoption, saysCCRAS - ETHealthworld
- Central Council for Research in Ayurvedic Sciences (CCRAS). Safety Protocols and Research Initiatives in Traditional Medicine. Ministry of Ayush, Government of India.
- National Pharmacovigilance Coordination Centre (NPvCC). Pharmacovigilance Program for ASU & H Drugs. All India Institute of Ayurveda, New Delhi.
